Search Results - "Vetter‐Kauczok, Claudia‐S."

Refine Results
  1. 1

    Overexpression of the KIT/SCF in Uveal Melanoma Does Not Translate into Clinical Efficacy of Imatinib Mesylate by Hofmann, Uta B., Kauczok-Vetter, Claudia S., Houben, Roland, Becker, Jürgen C.

    Published in Clinical cancer research (01-01-2009)
    “…Purpose: Recently, gene amplification and overexpression of KIT as well as activating mutations in the KIT gene have been described to occur in certain subsets…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Anetodermic pilomatricoma by De Souza, Elemir M., Ayres Vallarelli, Andrelou F., Cintra, Maria L., VetterKauczok, ClaudiaS., Brocker, Eva‐B.

    Published in Journal of cutaneous pathology (01-01-2009)
    “…A pilomatricoma, or Malherbe’s calcifying epithelioma, is an uncommon tumor originating from hair matrix cells. It is clinically characterized by a solitary,…”
    Get full text
    Journal Article
  4. 4

    Phospho-ERK Staining Is a Poor Indicator of the Mutational Status of BRAF and NRAS in Human Melanoma by Houben, Roland, Vetter-Kauczok, Claudia S., Ortmann, Sonja, Rapp, Ulf R., Broecker, Eva B., Becker, Juergen C.

    Published in Journal of investigative dermatology (01-08-2008)
    “…Mutated BRAF and NRAS are suspected to contribute to melanomagenesis by activation of extracellular signal-regulated kinase (ERK). To test this notion, we…”
    Get full text
    Journal Article
  5. 5

    Expression and Function of Macrophage Migration Inhibitory Factor in the Pathogenesis of UV-Induced Cutaneous Nonmelanoma Skin Cancer by Heise, Ruth, Vetter-Kauczok, Claudia S., Skazik, Claudia, Czaja, Katharina, Marquardt, Yvonne, Lue, Hongqi, Merk, Hans F., Bernhagen, Jürgen, Baron, Jens M.

    Published in Photochemistry and photobiology (01-09-2012)
    “…Chronic skin exposure to ultraviolet light stimulates the production of cytokines known to be involved in the initiation of skin cancer. Recent studies in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    p53 regulation by TRP2 is not pervasive in melanoma by Houben, Roland, Schmid, Corinna P, Maier, Melissa, Wobser, Marion, Motschenbacher, Stephanie, Becker, Jürgen C, Vetter-Kauczok, Claudia S, Weyandt, Gerhard, Hesbacher, Sonja, Haferkamp, Sebastian

    Published in PloS one (27-01-2014)
    “…p53 is a central tumor suppressor protein and its inhibition is believed to be a prerequisite for cancer development. In approximately 50% of all malignancies…”
    Get full text
    Journal Article
  8. 8

    Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult by Vetter-Kauczok, Claudia S, Ströbel, Philipp, Bröcker, Eva B, Becker, Jürgen C

    “…Kaposiform hemangioendothelioma (KHE) is a locally aggressive vascular tumor which usually occurs in infants. Clinically it appears as ill-defined red to…”
    Get full text
    Journal Article
  9. 9

    Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma by Krejsgaard, Thorbjørn, Vetter-Kauczok, Claudia S., Woetmann, Anders, Kneitz, Hermann, Eriksen, Karsten W., Lovato, Paola, Zhang, Qian, Wasik, Mariusz A., Geisler, Carsten, Ralfkiaer, Elisabeth, Becker, Juergen C., Ødum, Niels

    Published in Blood (04-06-2009)
    “…B-lymphoid kinase (Blk) is exclusively expressed in B cells and thymocytes. Interestingly, transgenic expression of a constitutively active form of Blk in the…”
    Get full text
    Journal Article
  10. 10

    CD147 Impacts Angiogenesis and Metastasis Formation by Voigt, Heike, Vetter-Kauczok, Claudia S., Schrama, David, Hofmann, Uta B., Becker, Jürgen C., Houben, Roland

    Published in Cancer investigation (01-01-2009)
    “…CD147 is highly expressed on many tumor cells; its role for tumor invasiveness and metastasis has been deduced from its capacity to induce MMPs, i.e., MMP-1,…”
    Get full text
    Journal Article
  11. 11

    Absence of Classical MAP Kinase Pathway Signalling in Merkel Cell Carcinoma by Houben, Roland, Michel, Barbara, Vetter-Kauczok, Claudia S., Pföhler, Claudia, Laetsch, Barbara, Wolter, Manfred D., Helen Leonard, J., Trefzer, Uwe, Ugurel, Selma, Schrama, David, Becker, Juergen C.

    Published in Journal of investigative dermatology (01-05-2006)
    “…Merkel cell carcinoma (MCC) is a highly metastatic skin tumor. To assess the relevance of the Ras/Raf/MEK/MAP kinase pathway, we analyzed for activating B-Raf…”
    Get full text
    Journal Article
  12. 12

    Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients by Hofmeister-Mueller, Valeska, Vetter-Kauczok, Claudia S, Ullrich, Ramona, Meder, Katharina, Lukanidin, Eugene, Broecker, Eva-Bettina, thor Straten, Per, Andersen, Mads Hald, Schrama, David, Becker, Juergen C

    Published in Cancer Immunology, Immunotherapy (01-08-2009)
    “…S100A4 (metastasin 1) belongs to the S100 family of Ca²⁺ binding proteins. While not present in most differentiated adult tissues, S100A4 is upregulated in the…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma by WOBSER, Marion, SIEDEL, Claudia, SCHRAMA, David, BRÖCKER, Eva-B, BECKER, Juergen C, VETTER-KAUCZOK, Claudia S

    Published in Archives of Dermatological Research (01-02-2006)
    “…Malignant melanoma of the skin preferentially metastasises via the lymphatic system. Novel molecular biomarkers, which are involved in malignant…”
    Get full text
    Journal Article
  15. 15

    Matrix metalloproteinase induction in the tumor stroma does not depend on CD147 expression in murine B16 melanoma by Voigt, Heike, Houben, Roland, Schrama, David, Hofmann, Uta B, Vetter-Kauczok, Claudia S, Becker, Jürgen C

    Published in Tumor biology (01-01-2007)
    “…It was conclusively demonstrated that the cell surface glycoprotein CD147 on tumor cells mediates induction of matrix metalloproteinases (MMPs) by stromal…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    p53 Regulation by TRP2 Is Not Pervasive in Melanoma: e87440 by Houben, Roland, Schmid, Corinna P, Maier, Melissa, Wobser, Marion, Motschenbacher, Stephanie, Becker, Juergen C, Vetter-Kauczok, Claudia S, Weyandt, Gerhard, Hesbacher, Sonja, Haferkamp, Sebastian

    Published in PloS one (01-01-2014)
    “…p53 is a central tumor suppressor protein and its inhibition is believed to be a prerequisite for cancer development. In approximately 50% of all malignancies…”
    Get full text
    Journal Article
  19. 19

    Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult by Becker, Jürgen

    Published in Vascular health and risk management (01-02-2008)
    “…Kaposiform hemangioendothelioma (KHE) is a locally aggressive vascular tumor which usually occurs in infants. Clinically it appears as ill-defined red to…”
    Get full text
    Journal Article
  20. 20

    BRAF super(V600E )mutations in malignant melanoma are associated with increased expressions of BAALC by Schrama, David, Keller, Gunhild, Houben, Roland, Ziegler, Christian G, Vetter-Kauczok, Claudia S, Ugurel, Selma, Becker, Juergen C

    Published in Journal of carcinogenesis (01-01-2008)
    “…Bachground Activating BRAF mutations are present in approximately 50% of melanomas. Although different downstream target genes of the most common mutant V600E…”
    Get full text
    Journal Article